Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Century Therapeutics Inc shares valued at $3,050 were sold by Carr Douglas on Jun 09 ’25. At $0.62 per share, Carr Douglas sold 4,904 shares. The insider’s holdings dropped to 405,982 shares worth approximately $0.24 million following the completion of this transaction.
Also, Farid Adrienne sold 552 shares, netting a total of over 343 in proceeds. Following the sale of shares at $0.62 each, the insider now holds 250,141 shares.
Before that, Pfeiffenberger Brent had sold 475 shares from its account. In a trade valued at $295, the President and CEO traded Century Therapeutics Inc shares for $0.62 each. Upon closing the transaction, the insider’s holdings decreased to 475 shares, worth approximately $0.99 million.
As published in their initiating research note from Rodman & Renshaw on August 08, 2024, Century Therapeutics Inc [IPSC] has been a Buy and the price target has been revised to $6. Analysts at JP Morgan downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late August. As of December 27, 2022, Chardan Capital Markets has initiated its “Buy” rating for IPSC. Earlier on October 31, 2022, Guggenheim initiated its rating. Their recommendation was “a Buy” for IPSC stock.
Analyzing IPSC Stock Performance
On last trading session,, Century Therapeutics Inc [NASDAQ: IPSC] plunged -0.81% to $0.59. The stock’s lowest price that day was $0.58, but it reached a high of $0.596 in the same session. During the last five days, there has been a drop of approximately -3.25%. Over the course of the year, Century Therapeutics Inc shares have dropped approximately -41.94%. Shares of the company reached a 52-week high of $1.1850 on 01/08/25 and a 52-week low of $0.3418 on 04/09/25.
Support And Resistance Levels for Century Therapeutics Inc (IPSC)
According to the 24-hour chart, there is a support level at 0.5789, which, if violated, would cause prices to drop to 0.5715. In the upper region, resistance lies at 0.5949. The next price resistance is at 0.6035. RSI (Relative Strength Index) is 53.34 on the 14-day chart, showing neutral technical sentiment.
Is Century Therapeutics Inc subject to short interest?
Stocks of Century Therapeutics Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.34 million shares to 2.41 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 2.75 million shares. A decline of -14.16% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.37 of the overall float, the days-to-cover ratio (short ratio) decline to 3.37.
Which companies own the most shares of Century Therapeutics Inc (IPSC)?
In terms of Century Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 2272.88% from the previous closing price of $0.59. Analysts anticipate Century Therapeutics Inc stock to reach 27 by 2025, with the lowest price target being 5. In spite of this, 4 analysts ranked Century Therapeutics Inc stock as Buy at the end of 2025. On October 10, 2022, Canaccord Genuity assigned a price target of “a Buy” to the stock and initiated coverage with a $28.
